Facebook
Twitter
LinkedIn
ForwardPrevention and Management of Toxicity in Organs at Risk (OAR) - (PRO 06)
This activity focuses entirely on issues related to the Organs at Risk (OAR) in the setting of thoracic radiation. Discussion centers on protecting the OARs and managing acute and late toxicities. Each speaker focuses on a different clinical situation. The clinical situations to be discussed are 1) conventionally fractionated lung treatment, 2) stereotactic body radiation therapy (SBRT) of peripheral lung lesions, and 3) SBRT for central/ultra-central lung lesions. Each speaker discusses dose constraints, planning techniques and technical solutions (e.g., gating, breath hold, tumor tracking etc.) to help decrease the dose to all critical OARs. Each speaker also discusses management of acute and late toxicity related to the treatment of lung cancer.
Target Audience
This activity is designed to meet the interests of radiation oncologists, dosimetrists and residents.
Learning Objectives
Upon completion of this activity, the participant should be able to do the following:
- Determine the appropriate dose constraints to be utilized in common clinical situations including SBRT to central and peripheral lung lesions.
- Assess common side effects of lung treatment and determine appropriate management.
- Christopher Hays Pope, MD, is employed by CARTI.
- Julianna K. Bronk, MD, PhD, is employed by The University of Texas MD Anderson Cancer Center.
- Matthew S. Ning, MD, MPH, is employed by MD Anderson Cancer Center.
- Shane Mesko, MD, MBA, is employed by University of California, Irvine.
All relevant financial relationships have been mitigated.
The person(s) above served as the developer(s) of this activity. Additionally, the Annual Meeting Steering Committee had control over the content of this activity.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
Available Credit
- 1.25 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.